✦ LIBER ✦

Sa1152 Long-Term Safety of Adalimumab in Pediatric Patients With Crohn's Disease

✍ Scribed by Rosh, Joel R.; Ruemmele, Frank; Dubinsky, Marla; Escher, Johanna C.; Kierkus, Jaroslaw; Hyams, Jeffrey S.; Lazar, Andreas; Eichner, Samantha; Li, Yao; Thakkar, Roopal

Book ID: 122128996
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 749 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60756-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P426 Long-term safety of adalimumab in p

P426 Long-term safety of adalimumab in paediatric patients with Crohn's disease

✍ Rosh, J.; Ruemmele, F.; Dubinsky, M.; Escher, J.; Kierkus, J.; Hyams, J.; Lazar, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 64 KB

Sa1201 Pharmacokinetics of Adalimumab in

Sa1201 Pharmacokinetics of Adalimumab in Pediatric Patients With Moderate to Severe Crohn's Disease

✍ Eckert, Doerthe; Mensing, Sven; Sharma, Shringi; Thakkar, Roopal; Robinson, Anne 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Long-term safety and efficacy of adalimu

Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease

✍ Watanabe, Mamoru; Hibi, Toshifumi; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 945 KB

O-30: Long-term efficacy of adalimumab i

O-30: Long-term efficacy of adalimumab in paediatric patients with Crohn’s disease

✍ Faubion, W.; Dubinsky, M.; Ruemmele, F.; Escher, J.; Rosh, J.; Lazar, A.; Eichne 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Adalimumab safety in global clinical tri

Adalimumab safety in global clinical trials of patients with Crohn's disease

✍ Jean-Frédéric Colombel; William J. Sandborn; Remo Panaccione; Anne M. Robinson; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

Background: Adalimumab, a fully human anti-tumor necrosis factor (anti-TNF) monoclonal antibody, is approved for the treatment of Crohn's disease (CD) in adults. We evaluated the overall safety profile of adalimumab in global clinical trials in patients with CD. Patients who participated in these tr

P.01.20 SAFETY OF LONG-TERM INFLIXIMAB A

P.01.20 SAFETY OF LONG-TERM INFLIXIMAB AND ADALIMUMAB TREATMENTS IN CROHN'S DISEASE

✍ Mazzuoli, S.; Regano, N.; Guglielmi, F.W. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB